Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
GHqLGeN6whZJypKW
